Evaluation of the immunotropic activity of neuropeptide compound Lys-Lys-Arg-Arg-Pro-Gly-Pro in conditions of "social" stress

Objective: to investigate immunotropic activity of the argenine-containing neuropeptide compound Lys-Lys-Arg-Arg-Pro-Gly-Pro in conditions of "social" stress. Material and methods. The study was conducted on mongrel male rats of 6 months of age using a model of "social" stress based on the provision of permanent residence of animals in conditions of sensory contact, as a result of which submissive and aggressive types of behavior were formed. All animals were divided into groups: control I - rats who were in a cage one at a time and received water for injection in an equivalent volume; control II - groups of stressed animals with aggressive and submissive types of behavior; three groups of stressed rats were intraperitoneally injected with Lys-Lys-Arg-Arg-Pro-Gly-Pro at a dose of 100 mcg/kg/day and the comparison drug Imunofan (Arginyl-alpha-aspartyl-lysyl-valyl-thyrosyl-argininum) at an average therapeutic dose of 0.7 mcg/kg/day. The following indicators were evaluated: delayed hypersensitivity reaction index, antibody titer of direct hemagglutination reaction, phagocytic activity of peripheral blood neutrophils, leukocyte formula indicators. Results. The results obtained in the course of this study indicate that the arginine-containing neuropeptide compound Lys-Lys-Arg-Arg-Pro-Gly-Pro contributes to the correction of immune changes that occur against the background of exposure to chronic "social" stress, namely, an increase in the delayed hypersensitivity reaction index, the level of anti-erythrocyte antibodies, the total number of leukocytes and a decrease in phagocytic activity of peripheral blood neutrophils (phagocytic number and phagocytic index), as well as restoration of the percentage ratio of elements of the leukocyte formula. Conclusion. Thus, the study of the immunotropic activity of the argenine-containing neuropeptide compound Lys-Lys-Arg-Arg-Pro-Gly-Pro showed the presence of an immunocorrecting effect on the cellular and humoral links of immunity, which actualizes the need for a detailed study of the immune mechanisms of this compound.

1. Cain D.W., Cidlowski J.A. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4): 233-247. DOI: 10.1038/nri.2017.1.

2. Straub R.H., Cutolo M. Psychoneuroimmunology-developments in stress research. Wien Med Wochenschr. 2018;168(3-4):76-84. DOI: 10.1007/s10354-017-0574-2.

3. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243-251. DOI: 10.1038/nri1571.

4. Pondeljak N., Lugović-Mihić L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Thers. 2020;42(5):757-770. DOI: 10.1016/j.clinthera.2020.03.008.

5. Russell G., Lightman S. The human stress response. Nat Rev Endocrinol. 2019;15(9):525-534. DOI: 10.1038/s41574-019-0228-0.

6. Dantzer R., Cohen S., Russo S.J., Dinan T.G. Resilience and immunity. Brain Behav Immun. 2018;74: 28-42. DOI: 10.1016/j.bbi.2018.08.010.

7. Baxter M., Ray D.W. Circadian rhythms in innate immunity and stress responses. Immunology. 2020;161(4):261-267. DOI: 10.1111/imm.13166.

8. Wei P., Keller C., Li L. Neuropeptides in gut-brain axis and their influence on host immunity and stress.Comput Struct Biotechnol J. 2020;18:843-851. DOI: 10.1016/j.csbj.2020.02.018.

9. Lotti T., D'Erme A.M., Hercogová J. The role of neuropeptides in the control of regional immunity. Clin Dermatol. 2014;32(5):633-645. DOI: 10.1016/j.clindermatol.2014.04.011.

10. Berczi I., Rotondo F., Kovacs K. Neuropeptides in Immunoregulation. In: Insights to Neuroimmune Biology. 2016:133-181. DOI: 10.1016/B978-0-12-801770-8.00007-0

11. Kolesnikova A.A., Tolstenok I.V., Fleishman M.Yu. Biological effects of proline-containing oligopeptides. Dal'nevostochnyj medicinskij zhurnal. 2021;(4):92-99 (in Russ). DOI: 10.35177/1994-5191-2021-4-19. EDN: UEOOFO.

12. Severyanova L.A., Bobyntsev I.I. Mechanisms of action of the amino acid L-arginine on the nervous and immune regulatory systems. Kursk scientific-practical bulletin «Man and his health». 2006;(3):60-75 (in Russ). EDN: KUCOIZ.

13. Avgustinovich D.F., Kovalenko I.L., Kudryavtseva N.N. A model of anxious depression: persistence of behavioral pathology. Neurosci Behav Physiol. 2005;35(9):917-924. DOI: 10.1007/s11055-005-0146-6.

14. Berger I., Werdermann M., Bornstein S.R., Steenblock C. The adrenal gland in stress - Adaptation on a cellular level. J Steroid Biochem Mol Biol. 2019;190:198-206. DOI: 10.1016/j.jsbmb.2019.04.006.

15. Yasenyavskaya A.L., Murtalieva V.H., Andreeva L.A., Samotrueva M.A., Myasoedov N.F. The effect of neuropeptides ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro on the state of the rat immune system in experimental depression. Astrakhan medical journal. 2019;14(3):94-103 (in Russ). DOI: 10.17021/2019.14.3.94.103. EDN: TYUAEM.

16. Shakespear M.R., Iyer A., Cheng C.Y., Das Gupta K., Singhal A., Fairlie D.P., Sweet M.J. Lysine Deacetylases and Regulated Glycolysis in Macrophages. Trends Immunol. 2018; 39(6): 473-488. DOI: 10.1016/j.it.2018.02.009.

17. Lee Y.C., Su Y.T., Liu T.Y., Tsai C.M., Chang C.H., Yu H.R. L-Arginine and L-Citrulline Supplementation Have Different Programming Effect on Regulatory T-Cells Function of Infantile Rats. Front Immunol. 2018;9:2911. DOI: 10.3389/fimmu.2018.02911.

18. Ognik K., Mikulski D., Konieczka P., Tykałowski B., Krauze M., Stępniowska A., Nynca A., Jankowski J. The immune status, oxidative and epigenetic changes in tissues of turkeys fed diets with different ratios of arginine and lysine. Sci Rep. 2021;11(1):15975. DOI: 10.1038/s41598-021-95529-y.